CALR and neoplasm: Specifically, when the nanodrugs disrupt the ER, ER stress induces imbalances in calcium homeostasis, and calreticulin (CRT) transfers from the ER to the cell membrane to act as an “eat-me” signal, inducing inflammatory cell infiltration and enhancing tumor cell antigens presented.